Is your child currently experiencing moderate to severe IBD flare-ups? Local CD study is testing a potential new medication to see if it may reduce recurrent diarrhea, fever, rectal pain, chronic fatigue, and/or anemia associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for 2–17 year olds to join a Crohn’s disease (CD) medical research study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or Crohn’s and ulcerative colitis (including associated symptoms such as cramps, fatigue, cramps, weight loss and/or liver disease), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing CD and UC flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce urgency to defecate, diarrhea, abdominal pain, frequent fevers, and/or joint pain associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children and teens 2–17 years of age to join a CD research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or gastrointestinal disease (including associated symptoms such as chronic diarrhea, blood in the stool, abdominal pain, weight loss and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce diarrhea, persistent diarrhea, diarrhea, chronic fatigue, and/or eye pain associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children 2 to 17 years old to join a UC clinical research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or moderate to severe UC (including associated symptoms such as tiredness, iron deficiency, diarrhea, chronic fatigue and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce chronic diarrhea, fistula, rectal pain, weight loss, and/or liver disease associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or CD and UC (including associated symptoms such as abdominal cramping, weight loss, constant need to poop, chronic fatigue and/or joint pain), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce stomach pain, loss of appetite, diarrhea, frequent fevers, and/or joint pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for young people aged 2 to 17 years to join a CD research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or gastrointestinal disease (including associated symptoms such as abdominal pain, perianal fistula, rectal pain, frequent fevers and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.